Babenco H D, Conard P F, Gross J B
Department of Anesthesiology, University of Connecticut School of Medicine, Farmington, 06030-2015, USA.
Anesthesiology. 2000 Feb;92(2):393-8. doi: 10.1097/00000542-200002000-00020.
In doses typically administered during conscious sedation, remifentanil may be associated with ventilatory depression. However, the time course of ventilatory depression after an initial dose of remifentanil has not been determined previously.
In eight healthy volunteers, the authors determined the time course of the ventilatory response to carbon dioxide using the dual isohypercapnic technique. Subjects breathed via mask from a to-and-fro circuit with variable carbon dioxide absorption, allowing the authors to maintain end-tidal pressure of carbon dioxide (PET(CO2)) at approximately 46 or 56 mm Hg (alternate subjects). After 6 min of equilibration, subjects received 0.5 microg/kg remifentanil over 5 s, and minute ventilation (V(E)) was recorded during the next 20 min. Two hours later, the study was repeated using the other carbon dioxide tension (56 or 46 mm Hg). The V(E) data were used to construct two-point carbon dioxide response curves at 30-s intervals after remifentanil administration. Using published pharmacokinetic values for remifentanil and the method of collapsing hysteresis loops, the authors estimated the effect-site equilibration rate constant (k(eo)), the effect-site concentration producing 50% respiratory depression (EC50), and the shape parameter of the concentration-response curve (gamma).
The slope of the carbon dioxide response decreased from 0.99 [95% confidence limits 0.72 to 1.26] to a nadir of 0.27 l x min(-1) x mm Hg(-1) [-0.12 to 0.66] 2 min after remifentanil (P<0.001); within 5 min, it recovered to approximately 0.6 l x min(-1) x mm Hg(-1), and within 15 min of injection, slope returned to baseline. The computed ventilation at PET = 50 mm Hg (VE50) decreased from 12.9 [9.8 to 15.9] to 6.1 l/min [4.8 to 7.4] 2.5 min after remifentanil injection (P<0.001). This was caused primarily by a decrease in tidal volume rather than in respiratory rate. Estimated pharmacodynamic parameters based on computed mean values of VE50 included k(eo) = 0.24 min(-1) (T1/2 = 2.9 min), EC50 = 1.12 ng/ml, and gamma = 1.74.
After administration of 0.5 microg/kg remifentanil, there was a decrease in slope and downward shift of the carbon dioxide ventilatory response curve. This reached its nadir approximately 2.5 min after injection, consistent with the computed onset half-time of 2.9 min. The onset of respiratory depression appears to be somewhat slower than previously reported for the onset of remifentanil-induced electroencephalographic slowing. Recovery of ventilatory drive after a small dose essentially was complete within 15 min.
在清醒镇静期间通常使用的剂量下,瑞芬太尼可能与通气抑制有关。然而,先前尚未确定首次给予瑞芬太尼后通气抑制的时间进程。
在8名健康志愿者中,作者使用双等碳酸血症技术确定了对二氧化碳通气反应的时间进程。受试者通过面罩从具有可变二氧化碳吸收的来回回路呼吸,使作者能够将呼气末二氧化碳分压(PET(CO2))维持在约46或56 mmHg(交替受试者)。平衡6分钟后,受试者在5秒内接受0.5μg/kg瑞芬太尼,并在接下来的20分钟内记录分钟通气量(V(E))。两小时后,使用另一种二氧化碳张力(56或46 mmHg)重复该研究。V(E)数据用于在给予瑞芬太尼后每隔30秒构建两点二氧化碳反应曲线。使用已发表的瑞芬太尼药代动力学值和消除滞后环的方法,作者估计了效应部位平衡速率常数(k(eo))、产生50%呼吸抑制的效应部位浓度(EC50)以及浓度-反应曲线的形状参数(γ)。
瑞芬太尼给药后2分钟,二氧化碳反应斜率从0.99 [95%置信区间0.72至1.26]降至最低点0.27 l×min(-1)×mmHg(-1) [-0.12至0.66](P<0.001);5分钟内,其恢复至约0.6 l×min(-1)×mmHg(-1),注射后15分钟内,斜率恢复至基线。PET = 50 mmHg时计算的通气量(VE50)在瑞芬太尼注射后2.5分钟从12.9 [9.8至15.9]降至6.1 l/min [4.8至7.4](P<0.001)。这主要是由于潮气量而非呼吸频率降低所致。基于VE50计算平均值估计的药效学参数包括k(eo) = 0.24 min(-1)(T1/2 = 2.9分钟)、EC50 = 1.12 ng/ml和γ = 1.74。
给予0.5μg/kg瑞芬太尼后,二氧化碳通气反应曲线的斜率降低且向下移位。这在注射后约2.5分钟达到最低点,与计算的起效半衰期2.9分钟一致。呼吸抑制的起效似乎比先前报道的瑞芬太尼诱导的脑电图减慢的起效稍慢。小剂量后通气驱动力的恢复在15分钟内基本完成。